ImmunityBio, Inc 10-Q for FY2020 Q2
ImmunityBio, Inc. (IBRX)
10-Q
2020-08-07
For: 2020-06-30
View Original
Added on
April 10, 2026
About this 10-Q
ImmunityBio, Inc filed this 10-Q on August 7, 2020, covering the quarter ended June 30, 2020 (FY2020 Q2).
Headline figures
Quarter ended June 30, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $1000
- down 94.1% from $17K a year earlier
- Net loss
- $20.09M
- compared with a net loss of $16.68M a year earlier